SCHEMBL19396267

SCHEMBL19396267

Cc1c(-c2ccc(C(=O)N3CCCCC3)s2)nn(C)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.46
ALDH1A1 P00352 7/20 0.46
YEATS4 O95619 1/20 0.46
POLB P06746 4/20 0.46
NPSR1 Q6W5P4 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
MAPK14 Q16539 1/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MAPT P10636 3/20 0.44
RXFP1 Q9HBX9 1/20 0.44
LMNA P02545 2/20 0.41
USP2 O75604 1/20 0.41
CREBBP Q92793 1/20 0.41
L3MBTL3 Q96JM7 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1593824 0.85 YEATS4 (0.44) HPGDALDH1A1YEATS4POLBNPSR1
SCHEMBL19396270 0.84 ALDH1A1 (0.46) HPGDALDH1A1YEATS4POLBNPSR1
SCHEMBL19396265 0.83 ALDH1A1 (0.43) HPGDALDH1A1YEATS4POLBNPSR1
SCHEMBL19396264 0.81 LIPE (0.44) HPGDALDH1A1YEATS4POLBNPSR1
SCHEMBL17624645 0.81 MAPT (0.47) HPGDALDH1A1YEATS4POLBNPSR1
SCHEMBL19396266 0.79 HPGD (0.47) HPGDALDH1A1YEATS4POLBNPSR1
SCHEMBL19396256 0.78 ALDH1A1 (0.46) HPGDALDH1A1YEATS4POLBNPSR1
SCHEMBL1594311 0.75 ALDH1A1 (0.43) HPGDALDH1A1YEATS4POLBNPSR1
SCHEMBL21230181 0.74 ALDH1A1 (0.45) HPGDALDH1A1YEATS4POLBNPSR1
SCHEMBL1593562 0.74 YEATS4 (0.45) HPGDALDH1A1YEATS4POLBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170273968-A1 MAO-B INHIBITORS AND REHABILITATION DART NEUROSCIENCE, LLC 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170273968-A1 MAO-B INHIBITORS AND REHABILITATION MAOB, MAOA, HTR2B HPGD 932/4885ALDH1A1 1300/4885YEATS4 2281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.